Pharmafile Logo
Pharmafocus logo
Advanced Search

Research and Development

Showing 15 posts of 9604 posts found.

Lilly HQ

Lilly hails progress of new R&D approaches

February 16, 2011 Research and Development, Sales and Marketing Chorus, Mirror Portfolio, R&D, lilly

Lilly says two of its experimental approaches to re-designing R&D are beginning to pay off.Like all of its peers, the …
Feature

Sanofi seals Genzyme deal for $20 billion

February 16, 2011 Research and Development, Sales and Marketing Genzyme, Sanofi

Sanofi-Aventis has finally agreed a deal to buy Genzyme for $20.1 billion after eight months of wrangling with the US …
News

R&D productivity worse than previously reported

February 15, 2011 Manufacturing and Production, Research and Development, Sales and Marketing BIO, BMT, FDA, R&D

A new analysis of pharma’s R&D pipelines suggests the overall success rate for drugs moving from clinical trials to FDA …
News
mosquito

Medivir and Janssen in dengue fever research alliance

February 14, 2011 Research and Development Dengue fever, Medivir

Medivir, the speciality pharma company focused on infectious diseases, it to collaborate with Janssen on discovering and developing new medicines …
News
Eli Lilly chief executive John Lechleiter

Lilly chief issues warning on UK reforms

February 11, 2011 Research and Development, Sales and Marketing John Lechleiter, US health reforms, healthcare reform, lilly, patent box, value-based pricing

Lilly chief executive John Lechleiter has warned that two key UK initiatives could fall seriously short of encouraging investment in …
News

Innovation is being stifled – Lilly chief executive

February 10, 2011 Research and Development, Sales and Marketing Economist 2011 Pharma Summit, US health reforms, healthcare costs, healthcare reform, lilly

Supporting medical innovation should be a fundamental requirement of healthcare reforms, but current public policies are failing to do this, …
News
Blog footer

Digital Pharma: This is how pharma is using digital

February 10, 2011 Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Android, Digital Pharma blog, Facebook, Twitter, disease awareness campaigns, ipad, iphone, social media

Pharma’s use of digital tools, from mobile apps to online campaigns to social media channels, is increasing all the time …
Feature
GSK's swine flu vaccine Pandemrix

WHO wants narcolepsy link with swine flu vaccine investigated

February 10, 2011 Research and Development, Sales and Marketing Finland Institute, GSK, GlaxoSmithKline, Pandemrix, narcolepsy, swine flu

The World Health Organisation has called for further investigation into GSK’s swine flu vaccine link to sleeping disorder narcolepsy, following …
News

Dr Mikael von Euler moves to Oncos Therapeutics

February 10, 2011 Research and Development Dr Mikael von Euler, Oncos Therapeutics, appointment, research and development

Finnish biotech company Oncos Therapeutics has appointed Dr Mikael von Euler as chief medical officer. He has more than 20 …
Appointment

Shire bags senior research execs from GSK and Abbott

February 9, 2011 Research and Development Dr Lawson Macartney, Dr Mario Saltarelli, Shire, appointment, recruitment, research and development

Shire has strengthened its speciality pharmaceuticals business with the appointment of senior research executives from GlaxoSmithKline and Abbott. Dr Lawson …
News

Dr Matthias joins Noxxon Pharma

February 9, 2011 Research and Development Dr Matthias Baumann, Noxxon Pharma, appointment, research and development

Berlin-based biotech Noxxon Pharma has appointed Dr Matthias Baumann as chief medical officers. He joins from Focus Clinical Drug Development, …
Appointment
Advanced melanoma

Melanoma: intense competition to be the next milestone treatment

February 9, 2011 Research and Development BRAF V600 mutation, Cancer, Tasigna, cancer research, melanoma, tremelimumab

A flurry of new data has emerged in the recent months from an industry-wide pipeline of cancer drugs which could …
Feature

AZ-Targacept depression candidate moves into phase IIb

February 9, 2011 Research and Development AZ, AstraZeneca, TC-5214, Targacept, depression, major depressive disorder

AstraZeneca and Targacept have begun a phase IIb trial of TC-5214 as a ‘switch’ monotherapy for patients with depression. The …
News
AstraZeneca's Iressa (gefitinib)

AZ and Pfizer support personalised medicine database

February 8, 2011 Research and Development AZ, AstraZeneca, Cancer Research UK, Iressa, Pfizer, crizotinib, gefitinib, personalised medicine

AstraZeneca and Pfizer have teamed up with leading charity Cancer Research UK to help develop its stratified medicines programme. Stratified …
News
Pfizer research Sandwich, Kent

Pressure mounts on Pfizer and government over UK R&D closure

February 7, 2011 Research and Development Kent, Pfizer, Sandwich, Science and Technology Select Committee

The political fallout over Pfizer’s decision to close its Kent R&D base continues apace, with the House of Commons to …
News
The Gateway to Local Adoption Series

Latest content

IsomAb appoints Philip Brainin as CEO

March 19, 2026

Naobios partners with SGS to manufacture RSV challenge agent

March 19, 2026

Qlaris Bio appoints Fred Guerard as President and CEO

March 18, 2026

Under-Secretary of State for Health Innovation and Safety visits new building on University of Huddersfield’s NHIC

March 18, 2026

AEON Biopharma appoints John Bencich as CFO

March 17, 2026